Circe D van der Heide
Overview
Explore the profile of Circe D van der Heide including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van der Heide C, Campeiro J, Ruigrok E, van den Brink L, Ponnala S, Hillier S, et al.
EJNMMI Res
. 2024 Dec;
14(1):125.
PMID: 39718718
Background: Fibroblast activation protein (FAP) is an attractive target for cancer theranostics. Although FAP-targeted nuclear imaging demonstrated promising clinical results, only sub-optimal results are reported for targeted radionuclide therapy (TRT)....
2.
van der Heide C, Ma H, Hoorens M, Campeiro J, Stuurman D, de Ridder C, et al.
EJNMMI Radiopharm Chem
. 2024 Jul;
9(1):55.
PMID: 39073475
Background: Fibroblast activation protein (FAP), a transmembrane serine protease overexpressed by cancer-associated fibroblasts in the tumor stroma, is an interesting biomarker for targeted radionuclide theranostics. FAP-targeting radiotracers have demonstrated to...
3.
van der Heide C, Dalm S
Eur J Nucl Med Mol Imaging
. 2022 Jul;
49(13):4616-4641.
PMID: 35788730
Targeted radionuclide theranostics is becoming more and more prominent in clinical oncology. Currently, most nuclear medicine compounds researched for cancer theranostics are directed towards targets expressed in only a small...